apl 130277 overview apl 130277 clinical trials apl 130277 published data parkinson s disease overview treatment of parkinson s disease off episodes in parkinson s disease current treatment of off episodes about apomorphine parkinson s resources investors company info company information profile presentations management team contacts faq news events news events press releases ir calendar email alerts financial info financial results stock data stock data quote cyna quote cth analyst coverage analyst coverage sec osc sec edgar annual reports quarterly reports osc sedar governance corporate governance board of directors board committees governance documents pfic info pfic statements news press releases in the news careers restoring movement with ease cynapsus is a specialty central nervous system cns pharmaceutical company developing and preparing to commercialize a fast acting easy to use sublingual thin film for the on demand management of debilitating off episodes associated with parkinson s disease pd . intro video analyst and investor day 2016 webcast presentation about cynapsus treating parkinsonssymptoms with ease product pipeline drug details and clinical studies information parkinson s disease resources for disease familiarity and management investors extensive resources for informed decision making about product pipeline parkinson s disease investors news careers 2016 cynapsus therapeutics inc. all rights reserved . privacy policy legal